Table 1 Patient demographics and covariates at the index admission in patients with COPD as primary diagnosis, underlying COPD and respiratory failure due to COPD
From: Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
AECOPD | any COPD | Respiratory failure | |
|---|---|---|---|
N (%) | 717 (20.2) | 2573 (72.4) | 265 (7.4) |
Men | 311 (43.4) | 1142 (44.4) | 109 (41.1) |
Women | 406 (56.6) | 1431 (55.6) | 156 (58.9) |
Age (years) | 72.8 (64.0–79.9) | 73.4 (63.6–81.3) | 73.4 (65.9–78.0) |
Charlson score | 1.0 (0–11) | 1.0 (0–11) | 1.0 (0–11) |
Length of stay (days) | 3.2 (0.8–7.8) | 2.2 (0.7–6.8) | 5.9 (1.8–12.0) |
CRP (mg/L) | 24.0 (6.0–75.0) | 15.0 (4.0–65.0) | 26.0 (7.0–86.0) |
suPAR (ng/mL) | 3.5 (2.6–5.0) | 3.8 (2.8–5.4) | 3.8 (2.8–5.3) |